Microbiome based diagnostic approaches

Area of Science:

• Microbiome research
• Cancer diagnostics
• Personalized medicine

Background:

• Head and Neck Cancers (HNC) are a significant global health concern, ranking seventh in incidence.
• Microbial dysbiosis in the head and neck region is linked to increased carcinogenesis.
• Traditional HNC diagnostics like biopsy are invasive; early detection is crucial for better survival rates.

Purpose of the Study:

• To provide an overview of microbiome-based diagnostic approaches for Head and Neck Cancers.
• To explore novel methods for detecting HNC-specific microbial biomarkers and signatures.
• To highlight the potential of salivary microbiome analysis in personalized medicine for HNC.

Main Methods:

• Review of current advancements in next-generation sequencing, third-generation sequencing, bioinformatics, and machine learning.
• Analysis of metagenomics, transcriptomics, and metabolomics for saliva-based diagnostics.
• Exploration of microbiome signatures for risk assessment, stratification, and prognosis.

Main Results:

• Salivary and mouth rinse microbiome analyses offer promising non-invasive screening tools for early HNC detection.
• Microbiome signatures are emerging as key components in personalized risk assessment and stratification for HNC.
• Advances in sequencing and bioinformatics enhance the utility of saliva as a diagnostic tool for various diseases.

Conclusions:

• Microbiome-based approaches, particularly salivary analysis, represent a paradigm shift in HNC detection and management.
• These non-invasive methods hold potential for early diagnosis, risk stratification, and monitoring treatment success.
• Harnessing the salivary microbiome aligns with the goals of personalized medicine for improved HNC patient outcomes.